Influenza virus-related critical illness: pathophysiology and epidemiology.
Kalil AC, Thomas PG.
Crit Care. 2019 Jul 19;23(1):258. doi: 10.1186/s13054-019-2539-x.
COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment.
Parasher A.
Postgrad Med J. 2021 May;97(1147):312-320. doi: 10.1136/postgradmedj-2020-138577. Epub 2020 Sep 25.
[Influenza virus].
Juozapaitis M, Antoniukas L.
Medicina (Kaunas). 2007;43(12):919-29.
Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract.
Flerlage T, Boyd DF, Meliopoulos V, Thomas PG, Schultz-Cherry S.
Nat Rev Microbiol. 2021 Jul;19(7):425-441. doi: 10.1038/s41579-021-00542-7. Epub 2021 Apr 6.
Airborne Precautions.
Ather B, Mirza TM, Edemekong PF.
2023 Mar 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
The role of influenza A virus-induced hypercytokinemia.
Wei F, Gao C, Wang Y.
Crit Rev Microbiol. 2022 Mar;48(2):240-256. doi: 10.1080/1040841X.2021.1960482. Epub 2021 Aug 5.
Modulation of alveolar macrophage and mitochondrial fitness by medicinal plant-derived nanovesicles to mitigate acute lung injury and viral pneumonia.
Ye L, Gao Y, Mok SWF, Liao W, Wang Y, Chen C, Yang L, Zhang J, Shi L.
J Nanobiotechnology. 2024 Apr 18;22(1):190. doi: 10.1186/s12951-024-02473-w.
B-cell lymphoma-2 family proteins-activated proteases as potential therapeutic targets for influenza A virus and severe acute respiratory syndrome coronavirus-2: Killing two birds with one stone?
Soni S, Mebratu YA.
Rev Med Virol. 2023 Mar;33(2):e2411. doi: 10.1002/rmv.2411. Epub 2022 Nov 30.
Bacteria and viruses and their role in the preschool wheeze to asthma transition.
Papadopoulos NG, Apostolidou E, Miligkos M, Xepapadaki P.
Pediatr Allergy Immunol. 2024 Mar;35(3):e14098. doi: 10.1111/pai.14098.
Exportin 1 inhibition as antiviral therapy.
Uddin MH, Zonder JA, Azmi AS.
Drug Discov Today. 2020 Oct;25(10):1775-1781. doi: 10.1016/j.drudis.2020.06.014. Epub 2020 Jun 20.
